Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Expression of SSEA-1 in the developing brain]

Makoto Yanagisawa1, Kazuo Nakamura, Tetsuya Taga

  • 121st Century COE Program, Cell Fate Regulation Research and Education Unit, Department of Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Honjo 2-2-1, Kumamoto 860-0811, Japan.

Seikagaku. the Journal of Japanese Biochemical Society
|October 28, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A transcriptional network underlying migratory cellular states and reduced 5-ALA-based photodynamic detectability in glioblastoma.

Molecular and clinical oncology·2026
Same author

The cytoskeletal regulator Coronin-1A plays a multidirectional role in glioblastoma stemness.

Scientific reports·2026
Same author

Ability to form Sox17-induced hematopoietic cell clusters varies among distinct hematopoietic sites during development.

Inflammation and regeneration·2026
Same author

Mutation of the histone demethylase Gasc1 causes ASD-like symptoms in mice.

Inflammation and regeneration·2025
Same author

Sox17 and Other SoxF-Family Proteins Play Key Roles in the Hematopoiesis of Mouse Embryos.

Cells·2024
Same author

Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment.

eLife·2024